Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Agusti (Palma De Mallorca, Spain). The adaptive immune system, autoimmunity and COPD: lessons from human studies. Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?

Member's Comments

No comment yet.

Related content which might interest you: Evasion of COPD in smokers: at what price? Source: Eur Respir J 2012; 39: 1298-1303 Year: 2012 Lymphoid follicles in (very) severe COPD: beneficial or harmful? Source: Eur Respir J 2009; 34: 219-230 Year: 2009 Why is it important to consider (sub)phenotypes of asthma and COPD? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 The adaptive immune system, autoimmunity and COPD: lessons from animal models Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD? Year: 2007 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 What is new in chronic obstructive pulmonary disease? Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=153 Year: 2007 Autoimmunity and pulmonary hypertension: a perspective Source: Eur Respir J 2005; 26: 1110-1118 Year: 2005 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Expression of MIC-A in bronchial epithelium associates with cigarette smoking: a sign of induced autoimmune mechanisms? Source: Annual Congress 2005 - Lung structure: current concepts Year: 2005 Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease Source: International Congress 2016 – Mechanisms of disease Year: 2016 Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly Source: Eur Respir J 2003; 21: 3S-9S Year: 2003 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Impact of viruses on airway diseases Source: Eur Respir Rev 2005; 14: 57-61 Year: 2005 Implications for disease and therapy Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005